Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial RNAs encompass all major classes—mRNAs encoding proteins; rRNAs forming part of ribosomes; tRNAs delivering amino acids; plus numerous regulatory sRNAs. They are synthesized by multi-subunit bacterial-specific polymerases using DNA templates. Their structure-function relationships underpin all aspects of prokaryotic gene regulation—from rapid response via sRNAs/riboswitches to bulk turnover managed by degradosomes—making them central targets for both basic research and antibiotic development efforts.
Drugs targeting bacterial RNA often inhibit transcription or translation, disrupting protein synthesis and bacterial growth. Examples include antibiotics that bind to bacterial ribosomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial RNA (RNA).